(BRK.A), (BRK.B)
Berkshire Hathaway, DaVita’s largest institutional investor, has sold 203,091 shares of the dialysis provider, reducing its ownership stake to 45%, according to a regulatory filing on Thursday. The transaction is part of an ongoing share repurchase agreement established between the two companies in April 2024.
Under the agreement, DaVita repurchases shares on a quarterly basis to ensure Berkshire’s stake remains at 45%. These buybacks are executed at a volume-weighted average price based on shares acquired from public investors during the period.
Over the years, Berkshire’s long-term ownership stake had been gradually increasing as DaVita continued its stock repurchases. This structured agreement provides an orderly mechanism for Berkshire to reduce its holdings while allowing DaVita to manage its capital structure effectively.
© 2025 David Mazor
Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.